$19.79
+1.0%National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Last Annual Value
0.00
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
| Company | Deferred Tax Liabilities (Non-Current) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() National Research Corporation NASDAQ:NRC | 0.00 | N/A | N/A | N/A | |
![]() Definitive Healthcare Corp. NASDAQ:DH | 14.63M | -39.8% | -28.1% | N/A | |
![]() Viemed Healthcare, Inc. NASDAQ:VMD | 15.79M | N/A | N/A | N/A | |
![]() Puma Biotechnology, Inc. NASDAQ:PBYI | 0.00 | N/A | N/A | N/A | |
![]() Spok Holdings, Inc. NASDAQ:SPOK | 0.00 | N/A | N/A | N/A | |
![]() SANUWAVE Health, Inc. NASDAQ:SNWV | 0.00 | N/A | N/A | N/A | |
![]() TruBridge, Inc. NASDAQ:TBRG | 2.58M | 28.1% | -28.6% | -2.3% | |
![]() Quanterix Corporation NASDAQ:QTRX | 32.38M | 201.9% | 35.8% | 27.7% | |
![]() Health Catalyst, Inc. NASDAQ:HCAT | 0.00 | N/A | N/A | N/A |
Continue your NRC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.